2016-06-15T23:59:19+05:302016-06-15T23:59:12+05:302016-06-15T23:59:19+05:30Acrobat PDFMaker 11 for Worduuid:d90367e8-45c6-4185-9d0d-134e85e11f01uuid:55ea821a-b9ef-4148-b9b0-802eb6c581d82xmlPERCUTANEOUS ELECTRICAL STIMULATION FOR MANAGEMENT OF MONOSYMPATOMATIC NOCTURNAL ENURESISptsecAdobe PDF Library 11.0D:20160606172242<egyptian hak>
International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: 0974-4304, ISSN(Online): 2455-9563 Vol.9, No.5, pp 81-85, 2016
Percutaneous Electrical Stimulation for Management of Monosympatomatic Nocturnal Enuresis Ashraf H. Mohamed1, Ibrahim M. Zoheiry2, Somaia A. Hamed2, Nevien Maher Waked3 1Physical therapy department for surgery, faculty of physical therapy, Cairo university, Egypt. 2Physical therapy department for surgery, faculty of physical therapy, October 6 University, Egypt. 3Department of pediatrics faculty of Medicine October 6 University, Egypt Abstract: The purpose of this study was to examine the effect of Percutaneous electrical stimulation therapy on children suffering from monosympatomatic nocturnal enuresis Subject: Thirty children ranging in age from 7 to 17 years. They received Percutaneous electrical stimulation on the sacral roots for 12weeks Methods: The wet nights were evaluated by bladder diary performed pre and post treatment. Patients were reevaluated one, three and six months after the last session. To evaluate the effectiveness of the method, the treatment response was scored according to the ICCS guidelines Results: After 6 months follow-up, 7 (23.3 %) patients presented 100% improvement of wet nights, 12 (40%) patients showed 90-99 % improvement, 3 (10%) patients showed partial improvement (50-89 %), and 8 (26.6 %) patients showed none response (0-49 %). Conclusion: Percutaneous electrical stimulation therapy has got clear effect in treatment of monosympatomatic nocturnal enuresis. Key Words: nocturnal enuresis, electrical stimulation. Introduction Nocturnal enuresis (NE) is a worldwide health problem frequently encountered in childhood and is defined as an involuntary voiding of urine during sleep with a frequency of at least twice a week in children, in the absence of congenital or acquired defects of the central nervous system1. Nocturnal enuresis includes monosymptomatic nocturnal enuresis (MNE) with no daytime urinary symptoms and non monosymptomatic nocturnal enuresis (NMNE) that is accompanied by daytime urinary symptoms. Nocturnal enuresis affects 5%–10% of younger school-age children2. Enuretic children have a higher risk for psychosocial co morbidity and loss of self-esteem. Such feelings of humiliation, guilt, and shame are also a reasonable source of heartache to the children and their parents3. Enuresis is called primary nocturnal enuresis when nighttime urinary control has never been gained and secondary nocturnal enuresis is defined as relapse after a dry period of at least 6 months. Although several etiologic factors have been described, the etiology of MNE is not clear now. These factors are reduced functional bladder capacity or large overnight urine production and the inability to awake when this occurs4. The abnormally large amounts of urine produced during sleep exceed the functional nocturnal bladder capacity. In addition, abnormalities in the arousal response to the full bladder have been observed, although the sleep patterns appear to be normal in children with nocturnal enuresis5. Typical symptoms of monosymptomatic enuresis are: deep sleep and difficult arousal, increased urine volume at night (polyuria) with large wetted volumes. The typical presentation is a child who is extremely difficult to wake and who wets the bed with large amounts of urine. In contrast, bladder function during the day is completely normal6. Delayed maturation in one or more of the following systems results in NE: a lack of stability in bladder function, a lack of arginine vasopressin (AVP) release or response, or relative increased solute excretion during the night, or an inability to wake from sleep to full bladder sensations. Combinations of all three problems may be present7. In normal children, the circadian rhythm of urine production results in a nocturnal reduction in dieresis to approximately 50% of daytime levels. Inchildren this is the result of nocturnal release of hormones that regulate free water excretion (arginine vasopressin, (AVP) or solute excretion (angiotensin II and aldosterone) and may result from circadian changes in glomerular filtration8. These children make more urine at night, and often overcome their bladder capacity and wet early in the night. Abnormalities can also be intrinsic, related to reduced nocturnal circadian changes in glomerular filtration rate (GFR) or in sodium and calcium excretion. Detection of low plasma vasopressin levels, GFR assessments or specific sodium and calcium excretion are difficult to measure9. The detrusor, in order to function appropriately, needs to be relaxed during filling and allow an appropriate functional capacity. Detrusor over activity usually causes small voided volumes resulting in a decreased functional bladder capacity10. These children had smaller functional bladder capacities at the point of wetting, than children with enuresis who did not have detrusor overactivity. Functional bladder capacity – defined as the largest daytime void on a frequency- volume (F/V) chart, after excluding the first morning void, may give a reasonably accurate assessment of daytime functional bladder capacity (FBC)11. The fundamental mechanism resulting in nocturia or NE is that the bladder fills to its capacity during sleep and needs to empty. Bladder fullness is due to nocturnal polyuria and/or a reduction of the bladder capacity due to detrusor over activity during sleep12. The low nocturnal antidiuretic hormone levels help to explain the failure in arousal in response to a full bladder, since there is impaired vasopressin production13. Primary therapeutic methods include behavioral therapy, conditioning with an alarm, medical therapies, hypnosis,pelvic floor muscle exercises, electrical stimulation, and acupuncture14. Methods Thirty participants complaining from primary monosymptomatic nocturnal enuresis participated in this study. They were selected from outpatient clinic of urology, Ein Shams specialized hospital, Ein Shams University, Cairo, Egypt. The course of treatment extended up to 12 weeks during the period of April 2014 to February 2016. Their ages ranged from 7 to 19 years. All participants were diagnosed by special physician to exclude the presence of Lower Urinary Tract Symptoms (LUTS), physical examination, urinalysis, and lumbo-sacral spine x-ray. The stimulation was conducted by a generator accurate pulse 195 LAUTZ. Two superficial 3 cm electrodes were placed on each side of S3 and S2. The session was performed three times/ week up to 12 weeks, for 30 min each and at a frequency of 30 Hz. The intensity was gradually increased to the maximum tolerable level; biphasic continuous waveform was used, with a pulse width of 250 microseconds. The wet nights were evaluated by bladder diary performed pre and post treatment. Patients were reevaluated one, three and six months after the last session. To evaluate the effectiveness of the method, the treatment response was scored according to the International Children Continence Society (ICCS) guidelines: Non response is defined as a 0% to 49% decrease of wet bed, partial response is defined as a 50% to 89% decrease, response is defined as a 90% or greater decrease and full response is defined as a 100% decrease of symptoms. Inclusion Criteria:
1. Children ages 7 to 17 years old without any specific neurological disorder (e.g spina bifida) or urinary tract infection.
2. Currently having no daytime overactive bladder symptoms, i.e. urinary frequency, urgency, or daytime incontinence
3. No behavioral etiologies of nocturnal enuresis (e.g drinking excess fluids or specific bladder irritants)
4. Don’t suffer from constipation
Exclusion Criteria:
1. Known neurological disorders.
2. Significant behavioral causes of enuresis.
3. Chronic constipation.
4. Not adequately potty trained
5. Significant daytime symptoms of overactive bladder including frequency, urgency.
6. Who do not tolerate initial stimulation training session.
7. Any implantable medical devices such as a pacemaker.
Results The wet nights were evaluated by bladder diary performed pre and post treatment. Patients were reevaluated one, three and six months after the last session. To evaluate the effectiveness of the method, the treatment response was scored according to the ICCS guidelines: Non response is defined as a 0% to 49% decrease of wet bed, partial response is defined as a 50% to 89% decrease, response is defined as a 90% or greater decrease and full response is defined as a 100% decrease of symptoms. Before treatment, 10 participants had wet nights every day, 8 participants had 16 wet nights per month, 7 participants had 12wet nights per month, and 5 participants had 8wet nights per month (Table 1). Table 1. Number of wet nights per month and the response to treatment in percentage according to the ICCS guidelines.
No./ month
Pre
After 1 month
After 3month
After 6 month
I
II
III
IV
I
II
III
IV
I
II
III
IV
30
10
8
1
1
0
7
2
1
0
5
2
2
1
16
8
4
2
2
0
2
1
3
2
1
0
4
3
12
7
3
0
2
2
2
1
2
2
1
1
3
2
8
5
1
0
3
1
1
1
2
1
1
0
3
1
I: 0-49% II: 50-89% III: 90-99% IV: 100% After 6 months follow-up, 7 (23.3 %) patients presented 100% improvement of wet nights, 12 (40%) patients showed 90-99 % improvement, 3 (10%) patients showed partial improvement (50-89 %), and 8 (26.6 %) patients showed none response (0-49 %). (Table 2). Table 2. Number and percentage of patients regarding to their response to treatment after 1, 3 and 6 months.
After 1 month
After 3 month
After 6 month
Full response
3 (10%)
5 (16.6%)
7 (23.3 %)
Response
8 (26.6%)
8 (26.6 %)
12 (40 %)
Partial response
3 (10 %)
5 (16.6 %)
3 (10%)
None response
16 (53.3 %)
12 (40 %)
8 (26.6 %)
Discussion Enuresis is a common condition which can cause severe psychological and social distress to children and their families15. The currently recommended treatment such as alarms, antidiuretic hormone, and anticholinergics are not effective in all patients, with significant relapse rate16,17. Electrical neural stimulation (ENS) has been used for OAB with good results in adults and in children18,19. Although the mechanisms of action of ENS are not fully elucidated, clinically there is improvement in urinary symptoms, in addition to modifications in the urodynamic pattern such increasing of cystometric bladder capacity and decreasing unstable contractions 20,21. The mechanism of ES has not yet been proved; however, most studies report that afferent sacral nerve stimulation causes an interneuronal change of the spinal reflex, which induces an inhibitory stimuli in the bladder efferent nerve22. However, consensus has not been reached concerning the precise mechanisms, and despite multiple efforts to examine the efficacy of such salvage treatment methods using ES, no gold standard method has been established, which causes frustration to the physician and patients and family members23. In the current study Electrical stimulation was well tolerated by all children, with no complaints such as pain or tenderness. Electrical stimulation was well tolerated by all children, with no complaints such as pain or tenderness. After 6 months follow-up, 7 (23.3 %) patients presented 100% improvement of wet nights, 12 (40%) patients showed 90-99 % improvement, 3 (10%) patients showed partial improvement (50-89 %), and 8 (26.6 %) patients showed none response (0-49 %). This were supported by the work of 24 who mentioned that; surface stimulation of sacral roots has a great effect in decreasing wet nights in children suffering from primary nocturnal enuresis. In our study, there was improvement in enuresis after ES. Decreased urinated volume in bed was observed in most patients, which may explain the high level of satisfaction with treatment even in those patients who remained daily wet nights. Conclusion ES seems to be a feasible option for treatment of monosymptomatic nocturnal enuresis with a decrease in the number of wet nights monthly. References
1. Nev´eus . T, von Gontard , P. Hoebeke et al., (2006): “The standardization of terminology of lower urinary tract function in children and adolescents: report fromthe Standardisation Committee of the International Children’s Continence Society,” The Journal of Urology ; 176, 1: 314–324.
2. Naseri .M and Hiradfar , (2012): “Monosymptomatic and nonmonosymptomatic nocturnal enuresis: a clinical evaluation,”Archives of Iranian Medicine ;15, (11) : 702–706.
3. Weaver and Dobson P, (2007): “ Nocturnal enuresis in children, “Journal of Family Health Care ; 17, (5) : 159–161.
4. Hagstroem S, Kamperis K, Rittig S et al., (2004): Monosymptomatic nocturnal enuresis is associated with abnormal nocturnal bladder emptying. J Urol; 171: 2562.
5. Unüvar T and Sönmez F , (2005): The role of urine osmolality and ions in the pathogenesis of primary enuresis nocturna and in the prediction of responses to desmopressin and conditioning therapies.Int Urol Nephrol ; 37: 751.
6. Wolfish NM, Pivik RT, Busby KA et al., (2007): Elevated sleep arousal thresholds in enuretic boys: clinical implications. Acta Paediatrica ; 86:381- 384.
7. Rittig, S., Schaumburg, H. L., Siggaard, C. et al., (2008): The circadian defect in plasma vasopressin and urine output is related to desmopressin response and enuresis status in children with nocturnal enuresis . Journal of Urology; 179: 2389.
8. de Guchtenaere , A., Vande Walle, C., Van Sintjan, P. et al., (2007): Nocturnal polyuria is related to absent circadian rhythm of glomerular filtration rate. Journal of Urology; 178: 2626.
9. Raes, A., Dehoorne, J., Hoebeke, P. et al., (2006) : Abnormal circadian rhythm of diuresis or nocturnal polyuria in a subgroup of children with enuresis and hypercalciuria is related to increased sodium retention during daytime. Journal of Urology ; 176: 1147.
10. Kruse, S., Hellstrom, A. L. and Hjalmas, K , (2009) : Daytime bladder dysfunction in therapy-resistant nocturnal enuresis. A pilot study in urotherapy. Scandinavian Journal of Urology & Nephrology; 33: 49
11. Medel, R., Dieguez, S., Brindo, M. et al., (2008) : Monosymptomatic primary enuresis: Differences between patients responding or not responding to oral desmopressin. British Journal of Urology ; 81 (3) : 46.
12. Fielding , (2000): The response of day and night wetting children and children who wet only at night to retention control training and the enuresis alarm. Behaviour Research & Therapy ; 18: 305.
13. DiMichele S, Sillen U, Engel J, Hjälmas K, Rubenson A, Söderpalm B et al., (2006): Desmopressin and vasopressin increase locomotor activity in rate via a central mechanism: Implications for nocturnal enuresis. JUrol;156:1164–1168.
14. Zhang D and Lu Y , (2002): Clinical application of the point baihui. J Tradit Chin Med; 22: 224.
15. Neveus T, Eggert P, Evans J, et al: Evaluation of and Treatment for Monosymptomatic Enuresis: A Standardization Document From the International Children’s Continence Society. J Urol 2010; 183: 441-447.
16. Glazener CM, and Evans JH: Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev 2003; 3: CD002117.
18. Bower, W. F., Moore, K. H.: A pilot study of the home application of transcutaneous neuromodulation in children with urgency or urge incontinence. J Urol 2001; 166: 2420-2422.
19. Hoebeke, P., Van Laecke, E., Everaert, K., et al: Transcutaneous neuromodulation for the urge syndrome in children: a pilot study. J Urol 2001; 166: 2416-2419.
20. Malm-Buatsi E, Nepple KG, Boyt MA, et al.: Efficacy of transcutaneous electrical nerve stimulation in children with OAB refractory to pharmacotherapy. Urology 2007; 70:980–983.
21. Barroso Jr.U, Tourinho R, Lordelo P, et al: Electrical Stimulation for Lower Urinary Tract Dysfunction in Children: A Systematic Review of the Literature. Neurourology and Urodynamics 2011: 30:1429–1436.
22. Kwak KW, Lee YS, Park KH, et al: Efficacy of desmopressin and enuresis alarm as first and second line treatment for primary monosymptomatic nocturnal enuresis: prospective randomized crossover study. J Urol 2010; 184(6):2521-2526.
23. Lindström S, Fall M, Carlsson CA, Erlandson BE. The neurophysiological basis of bladder inhibition in response to intravaginal electrical stimulation. J Urol. 1983;129:405–410.
24. Raheem AA, Farahat Y, El-Gamal O,et al: Role of Posterior Tibial Nerve Stimulation in the Treatment of Refractory Monosymptomatic Nocturnal Enuresis: A Pilot Study. J Urol 2013; 189:1514-1518.